Share of privately insured enrollees receiving ACA preventive care potentially affected by Braidwood v. Becerra, by market, 2019

Note: These represent major preventive services and drugs potentially affected by Braidwood v. Becerra. This analysis does not include pre-exposure prophylaxis (PrEP) for adults at risk of HIV and colorectal cancer screenings for adults ages 45-49 because they were recommended in mid-2019 or later. See "Use of ACA preventive services potentially affected by Braidwood v. Becerra" for potentially affected populations.
Source: KFF analysis of 2019 Merative MarketScan and 2019 EDGE data Get the data
KFF